Pacira BioSciences
Yahoo Finance • 13 days ago
PharmaCorp Rx Inc. To Present At The 2026 Bloom Burton & Co. Healthcare Investor Conference
SASKATOON, Saskatchewan, April 02, 2026 (GLOBE NEWSWIRE) -- PharmaCorp Rx Inc. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) a Canadian pharmacy services and consolidation platform, announced today that it will deliver a corporate pre... Full story
Yahoo Finance • 15 days ago
Pacira (PCRX) BioSciences Well-Positioned With Genicular Outcomes Registry Evidence
Pacira BioSciences Inc. (NASDAQ:PCRX) is one of the 7 best small-cap drug manufacturing stocks to buy according to hedge funds. On March 2, Pacira BioSciences Inc. (NASDAQ:PCRX) presented data from its IGOR registry at the American Academ... Full story
Yahoo Finance • last month
Pacira BioSciences Reaffirms Commitment to Shareholder Value Creation
-- Issues Statement in Response to DOMA’s Nomination of Director Candidates -- -- No Shareholder Action Required at This Time -- BRISBANE, Calif., March 11, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry... Full story
Yahoo Finance • last month
Sector Update: Health Care Stocks Lower Late Afternoon
Health care stocks were slipping late Wednesday afternoon, with the NYSE Health Care Index down 0.5% PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story
Yahoo Finance • last month
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BRISBANE, Calif., March 06, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of patients, today announced the granting o... Full story
Yahoo Finance • 3 months ago
PharmaCorp Announces Grant of Stock Options
SASKATOON, Saskatchewan, Dec. 31, 2025 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) has granted a total of 501,088 options to purchase common shares to directors, officers, employees and consul... Full story
Yahoo Finance • 3 months ago
DOMA intends to nominate three director candidates at Pacira annual meeting
DOMA Perpetual Capital Management, which beneficially owns approximately 6.83% of the outstanding shares of Common Stock of Pacira (PCRX) BioSciences, announced that it intends to nominate three independent director candidates at the Compa... Full story
Yahoo Finance • 5 months ago
Pharmacorp Rx Inc. Reports Q3 2025 Financial Results
SASKATOON, Saskatchewan, Nov. 28, 2025 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) a growing national platform for pharmacist-led community pharmacy ownership, today reported its financial resu... Full story
Yahoo Finance • 5 months ago
PharmaCorp Announces Executive Transition and New Director of Business Development
SASKATOON, Saskatchewan, Nov. 28, 2025 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) today announced an executive transition in which Paul Dale has been appointed President and Chief Operating Of... Full story
Yahoo Finance • 5 months ago
Pacira BioSciences Files EXPAREL® Patent Infringement Lawsuits Against The WhiteOak Group and Qilu Pharmaceutical
-- Lawsuit triggers 30-month stay under the Hatch Waxman Act -- BRISBANE, Calif., Nov. 26, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain th... Full story
Yahoo Finance • 5 months ago
PharmaCorp Announces Supplemental Listing of Warrants
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES SASKATOON, Saskatchewan, Nov. 13, 2025 (GLOBE NEWSWIRE) -- PharmaCorp Rx Inc. (“PharmaCorp” or the “Company”) (TSXV: PCRX) is pleased to... Full story
Yahoo Finance • 5 months ago
PharmaCorp Announces Closing of C$23 Million Bought Deal Public Offering
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, Nov. 12, 2025 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. – PharmaCorp Rx Inc. (“PharmaCorp” or the “Company”) (TSXV: PCRX)... Full story
Yahoo Finance • 5 months ago
PharmaCorp Announces Upsized C$20 Million Bought Deal Public Offering
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES SASKATOON, Saskatchewan, Nov. 06, 2025 (GLOBE NEWSWIRE) -- PharmaCorp Rx Inc. (“PharmaCorp” or the “Company”) (TSXV: PCRX) is pleased to... Full story
Yahoo Finance • 5 months ago
PharmaCorp Announces C$15 Million Bought Deal Public Offering
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES SASKATOON, Saskatchewan, Nov. 05, 2025 (GLOBE NEWSWIRE) -- PharmaCorp Rx Inc. (“PharmaCorp” or the “Company”) (TSXV: PCRX) is pleased to... Full story
Yahoo Finance • 5 months ago
Pacira to Report Third Quarter 2025 Financial Results on Thursday November 6, 2025
BRISBANE, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced that... Full story
Yahoo Finance • 6 months ago
Pacira BioSciences Notified of Abbreviated New Drug Application Filing from Qilu Pharmaceutical (Hainan) Co., Ltd. for EXPAREL®
BRISBANE, Calif., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients today reported it has... Full story
Yahoo Finance • 6 months ago
Pacira down after FDA filing for generic Exparel
[painkillers, dependence on pills. The concept] Pavel Kot/iStock via Getty Images Shares of Pacira BioSciences (NASDAQ:PCRX [https://seekingalpha.com/symbol/PCRX]) fell on Tuesday after the company announced that a subsidiary of a Chinese... Full story
Yahoo Finance • 6 months ago
Pacira BioSciences to Present 3-Year Data Demonstrating Sustained Pain and Function Improvements in Knee Osteoarthritis with Investigational PCRX-201 Gene Therapy
-- Poster to be presented at American College of Rheumatology Convergence 2025 – BRISBANE, Calif., Oct. 20, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX), the industry leader in its commitment to deliver innovative,... Full story
Yahoo Finance • 6 months ago
PharmaCorp Rx Inc. Files Final Short Form Base Shelf Prospectus
SASKATOON, Saskatchewan, Oct. 17, 2025 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV:PCRX) is pleased to announce that it has filed its Final Short Form Base Shelf Prospectus dated October 14, 2025 (the... Full story
Yahoo Finance • 6 months ago
PharmaCorp Refiles Q2 2025 Financial Statements
SASKATOON, Saskatchewan, Oct. 10, 2025 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) has restated and refiled its financial statements for the interim period ended June 30, 2025 (the “Amended Q2... Full story
